Advanced search
Publication Cover
Critical Reviews in Biotechnology Volume 36, 2016 - Issue 4
Submit an article Journal homepage
2,250
Views
221
CrossRef citations to date
0
Altmetric
Review Article

Molecular mechanisms of drug resistance and its reversal in cancer

Melis Kartal-YandimDepartment of Molecular Biology and Genetics, İzmir Institute of Technology, Urla, İzmir, Turkey and
,
Aysun Adan-GokbulutDepartment of Molecular Biology and Genetics, İzmir Institute of Technology, Urla, İzmir, Turkey and
&
Yusuf BaranDepartment of Molecular Biology and Genetics, İzmir Institute of Technology, Urla, İzmir, Turkey and ;Faculty of Life and Natural Sciences, Abdullah Gul University, Kayseri, TurkeyCorrespondence[email protected]
Pages 716-726 | Received 05 Oct 2013, Accepted 21 Dec 2014, Published online: 11 Mar 2015

Citations (221)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (10)

Ruijun Ju, Faliang Wu, Yanzhao Tian, Jiahao Chu, Xiaoming Peng & Xiaobo Wang. (2023) Dual Sensitization Anti-Resistant Nanoparticles for Treating Refractory Breast Cancers via Apoptosis-Inducing. Drug Design, Development and Therapy 17, pages 403-418.
Read now
Wonyi Jang, Mijung Im, Jungwook Roh, JiHoon Kang & Wanyeon Kim. (2023) Hippo-YAP/TAZ pathway regulation: the crucial roles of lncRNAs in cancer. Animal Cells and Systems 27:1, pages 309-320.
Read now
Xuhua Duan, Wenze Xu, Hao Li, Manzhou Wang, Wenhui Wang, Huibin Lu, Yancang Zhang & Xinwei Han. (2022) Nrf2-siRNA Enhanced the Anti-Tumor Effects of As2O3 in 5-Fluorouracil-Resistant Hepatocellular Carcinoma by Inhibiting HIF-1α/HSP70 Signaling. Journal of Hepatocellular Carcinoma 9, pages 1341-1352.
Read now
Mengge Chen, Yanpeng Ding, Yuan Ke, Yifei Zeng, Nuomin Liu, Yahua Zhong, Xinying Hua, Zheng Li, Yudi Xiong, Chaoyan Wu & Haijun Yu. (2020) Anti-tumour activity of zinc ionophore pyrithione in human ovarian cancer cells through inhibition of proliferation and migration and promotion of lysosome-mitochondrial apoptosis. Artificial Cells, Nanomedicine, and Biotechnology 48:1, pages 824-833.
Read now
Yao-Jie Pan, Jian Wan & Chun-Bin Wang. (2019) MiR-326: Promising Biomarker for Cancer. Cancer Management and Research 11, pages 10411-10418.
Read now
Sirui Li, Guo Li, Taofeng Zhang, Jili Li, Quanyi Zhao, Baoping Zhang, Rui Wang, Rong Zhou, Jing Si, Lu Gan, Yang Liu, Hong Zhang & Bin Liu. (2019) Co-SLD suppressed the growth of oral squamous cell carcinoma via disrupting mitochondrial function. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 1746-1757.
Read now
Shanshan Jiang, Yanhua Mou, Huiyang He, Dandan Yang, Li Qin, Fang Zhang & Peng Zhang. (2019) Preparation and evaluation of self-assembly Soluplus®-sodium cholate-phospholipid ternary mixed micelles of docetaxel. Drug Development and Industrial Pharmacy 45:11, pages 1788-1798.
Read now
Yu Xia, Lixia Jiang & Tianyu Zhong. (2018) The role of HIF-1α in chemo-/radioresistant tumors. OncoTargets and Therapy 11, pages 3003-3011.
Read now
Wing-Hin Lee, Ching-Yee Loo, Chean-Ring Leong, Paul M. Young, Daniela Traini & Ramin Rohanizadeh. (2017) The achievement of ligand-functionalized organic/polymeric nanoparticles for treating multidrug resistant cancer. Expert Opinion on Drug Delivery 14:8, pages 937-957.
Read now
Qi Fu, Yong Du, Chun Yang, Dong Zhang, Ningmei Zhang, Xiaoming Liu, William C. Cho & Yinxue Yang. (2016) An oncogenic role of miR-592 in tumorigenesis of human colorectal cancer by targeting Forkhead Box O3A (FoxO3A). Expert Opinion on Therapeutic Targets 20:7, pages 771-782.
Read now

Articles from other publishers (211)

Yuri Nagaoka, Kotone Oshiro, Yuta Yoshino, Toshiyuki Matsunaga, Satoshi Endo & Akira Ikari. (2024) Activation of the TGF-β1/EMT signaling pathway by claudin-1 overexpression reduces doxorubicin sensitivity in small cell lung cancer SBC-3 cells. Archives of Biochemistry and Biophysics 751, pages 109824.
Crossref
Farid Hajareh Haghighi, Roya Binaymotlagh, Ilaria Fratoddi, Laura Chronopoulou & Cleofe Palocci. (2023) Peptide-Hydrogel Nanocomposites for Anti-Cancer Drug Delivery. Gels 9:12, pages 953.
Crossref
Patrycja Jastrząb, Karolina Narejko, Halina Car & Przemyslaw Wielgat. (2023) Cell Membrane Sialome: Sialic Acids as Therapeutic Targets and Regulators of Drug Resistance in Human Cancer Management. Cancers 15:20, pages 5103.
Crossref
Begum Dariya, Bala Prabhakar Girish, Neha Merchant, Mundla Srilatha & Ganji Purnachandra Nagaraju. (2023) Resveratrol: biology, metabolism, and detrimental role on the tumor microenvironment of colorectal cancer. Nutrition Reviews.
Crossref
Yongfei Zhao, Ke Xue, Jing Deng & Zhengjian Qi. (2023) From cell membrane to mitochondria: Time-dependent AIE photosensitizer for fluorescence imaging and photodynamic anticancer therapy. Sensors and Actuators B: Chemical 393, pages 134255.
Crossref
Jyoti Chandra, Nazeer Hasan, Nazim Nasir, Shadma Wahab, Punniyakoti Veeraveedu Thanikachalam, Amirhossein Sahebkar, Farhan Jalees Ahmad & Prashant Kesharwani. (2023) Nanotechnology-empowered strategies in treatment of skin cancer. Environmental Research 235, pages 116649.
Crossref
Joop A. Peters & Kristina Djanashvili. (2023) Exploration and exploitation of the uncommon pH profile of the dynamic covalent interactions between boronic acids and N-acetylneuraminic acids. Coordination Chemistry Reviews 491, pages 215254.
Crossref
Han Han, Lei Xing, Bi-Te Chen, Yang Liu, Tian-Jiao Zhou, Yi Wang, Ling-Feng Zhang, Ling Li, Chong-Su Cho & Hu-Lin Jiang. (2023) Progress on the pathological tissue microenvironment barrier-modulated nanomedicine. Advanced Drug Delivery Reviews 200, pages 115051.
Crossref
Juan Li, Yongjing Cao, Xiaojie Zhang, Min An & Yanhua Liu. (2023) The Application of Nano-drug Delivery System With Sequential Drug Release Strategies in Cancer Therapy. American Journal of Clinical Oncology.
Crossref
Shuo Xiang, Jia Liu, Guangze Han, Wei Zhang, Yanyang Long, Yuxian Deng, Binju Wang & Qunhong Weng. (2023) Design of red-emitting 1D zinc coordination polymer for targeted drug delivery to nucleus. Chemical Engineering Journal 470, pages 144177.
Crossref
Fan Tong, Yang Zhou, Yanyan Xu, Yuxiu Chen, Natalia Yudintceva, Maxim Shevtsov & Huile Gao. (2023) Supramolecular nanomedicines based on host–guest interactions of cyclodextrins. Exploration 3:4.
Crossref
Chengyu Liu, Hong Chen, Bicheng Hu, Jiajian Shi, Yuchen Chen & Kun Huang. (2023) New insights into the therapeutic potentials of statins in cancer. Frontiers in Pharmacology 14.
Crossref
Gera Narendra, Baddipadige Raju, Himanshu Verma, Manoj Kumar, Subheet Kumar Jain, Gurleen Kaur Tung, Shubham Thakur, Rasdeep Kaur, Satwinderjeet Kaur, Bharti Sapra, Pankaj Kumar Singh & Om Silakari. (2023) Raloxifene and bazedoxifene as selective ALDH1A1 inhibitors to ameliorate cyclophosphamide resistance: A drug repurposing approach. International Journal of Biological Macromolecules 242, pages 124749.
Crossref
Yanwei Song, Zheng Deng, Haoran Sun, Yucui Zhao, Ruyi Zhao, Jin Cheng & Qian Huang. (2023) Predicting tumor repopulation through the gene panel derived from radiation resistant colorectal cancer cells. Journal of Translational Medicine 21:1.
Crossref
Júlia German-Cortés, Mireia Vilar-Hernández, Diana Rafael, Ibane Abasolo & Fernanda Andrade. (2023) Solid Lipid Nanoparticles: Multitasking Nano-Carriers for Cancer Treatment. Pharmaceutics 15:3, pages 831.
Crossref
Runmei Li, Dong Zhang, Baozhu Ren, Shui Cao, Li Zhou, Yanjuan Xiong, Qian Sun & Xiubao Ren. (2023) Therapeutic effect of haploidentical peripheral blood stem cell treatment on relapsed/refractory ovarian cancer. Bulletin du Cancer 110:3, pages 285-292.
Crossref
Liang-Hsin Chen, Nai-Wen Liang, Wei-Yuan Huang, Yu-Chung Liu, Chia-Yu Ho, Chen-Hsiang Kuan, Yu-Fen Huang & Tzu-Wei Wang. (2023) Supramolecular hydrogel for programmable delivery of therapeutics to cancer multidrug resistance. Biomaterials Advances 146, pages 213282.
Crossref
Minsu Park, Kyoung Sunwoo, Yoon-Jae Kim, Miae Won, Yunjie Xu, Jaewon Kim, Zhongji Pu, Mingle Li, Ji Young Kim, Jae Hong Seo & Jong Seung Kim. (2023) Cutting Off H + Leaks on the Inner Mitochondrial Membrane: A Proton Modulation Approach to Selectively Eradicate Cancer Stem Cells . Journal of the American Chemical Society.
Crossref
·买合木提 祖丽皮耶. (2023) Advances in the Role of Nrf2 in the Development of Breast Cancer and the Development of Drug Resistance. Advances in Clinical Medicine 13:10, pages 16361-16367.
Crossref
Shuya Wang, Shuangyu Yang, Xiaojia Yang, Dan Deng, Jie Li & Mingqing Dong. (2023) Research Progress of Traditional Chinese Medicine Monomers in Reversing Multidrug Resistance of Breast Cancer. The American Journal of Chinese Medicine 51:03, pages 575-594.
Crossref
Fatemeh Zahedipour, Prashant Kesharwani & Amirhossein Sahebkar. 2023. Aptamers Engineered Nanocarriers for Cancer Therapy. Aptamers Engineered Nanocarriers for Cancer Therapy 51 83 .
Mohamad Bahij Moumneh, Tarek Bou Dargham, Marguerite Mrad & Ghassan Dbaibo. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology 1 39 .
Yuanjun Sun, Wenhao Tang, Huxin Ni, Mei Wang, Bin Huang & Ya-Qiu Long. (2022) Convergent synthesis of tetrahydropyranyl side chain of verucopeptin, an antitumor antibiotic active against multidrug-resistant cancers. Chemical Communications 58:97, pages 13447-13450.
Crossref
Juliana Santos Rosa Viegas, Maria Vitória Lopes Badra Bentley & Fabiana Testa Moura de Carvalho Vicentini. (2022) Challenges to perform an efficiently gene therapy adopting non-viral vectors: Melanoma landscape. Journal of Drug Delivery Science and Technology 78, pages 103964.
Crossref
Megha Mariya Jacob, Amritha Santhosh, Anjaly Rajeev, Reshma Joy, Pooja Mary John, Franklin John & Jinu George. (2022) Current Status of Natural Products/siRNA Co‐Delivery for Cancer Therapy. ChemistrySelect 7:44.
Crossref
Shuang Qin, Yuting Wang, Peijun Wang & Qi Lv. (2022) Molecular mechanism of circRNAs in drug resistance in renal cell carcinoma. Cancer Cell International 22:1.
Crossref
Dayana N. Chernyshova, Alexander A. Tyulin, Olga S. Ostroumova & Svetlana S. Efimova. (2022) Discovery of the Potentiator of the Pore-Forming Ability of Lantibiotic Nisin: Perspectives for Anticancer Therapy. Membranes 12:11, pages 1166.
Crossref
Xun Zhang, Mingpeng Luo, Jiahang Zhang, Bize Guo, Shreya Singh, Xixi Lin, Hanchu Xiong, Siwei Ju, Linbo Wang, Yulu Zhou & Jichun Zhou. (2022) The role of lncRNA H19 in tumorigenesis and drug resistance of human Cancers. Frontiers in Genetics 13.
Crossref
Yuliannis Lugones, Pía Loren & Luis A. Salazar. (2022) Cisplatin Resistance: Genetic and Epigenetic Factors Involved. Biomolecules 12:10, pages 1365.
Crossref
Sami A. Gabr, Wael M. Elsaed, Mohamed Ahmed Eladl, Mohamed El-Sherbiny, Hasnaa Ali Ebrahim, Saad Mohamed Asseri, Yasir A. M. Eltahir, Nehal Elsherbiny & Mamdouh Eldesoqui. (2022) Curcumin Modulates Oxidative Stress, Fibrosis, and Apoptosis in Drug-Resistant Cancer Cell Lines. Life 12:9, pages 1427.
Crossref
Huijuan Zhang, Jiaxing Pan, Tingting Wang, Yi Lai, Xiaoying Liu, Fangmin Chen, Leiming Xu, Xiongwei Qu, Xiuli Hu & Haijun Yu. (2022) Sequentially Activatable Polypeptide Nanoparticles for Combinatory Photodynamic Chemotherapy of Breast Cancer. ACS Applied Materials & Interfaces 14:35, pages 39787-39798.
Crossref
Thaís Moré Milan, Ana Patrícia Espaladori Eskenazi, Rayana Longo Bighetti-Trevisan & Luciana Oliveira de Almeida. (2022) Epigenetic modifications control loss of adhesion and aggressiveness of cancer stem cells derived from head and neck squamous cell carcinoma with intrinsic resistance to cisplatin. Archives of Oral Biology 141, pages 105468.
Crossref
Terra G. Arnason, Valerie MacDonald-Dickinson, Matthew Casey Gaunt, Gerald F. Davies, Liubov Lobanova, Brett Trost, Zoe E. Gillespie, Matthew Waldner, Paige Baldwin, Devon Borrowman, Hailey Marwood, Frederick S. Vizeacoumar, Franco J. Vizeacoumar, Christopher H. Eskiw, Anthony Kusalik & Troy A. A. Harkness. (2022) Activation of the Anaphase Promoting Complex Reverses Multiple Drug Resistant Cancer in a Canine Model of Multiple Drug Resistant Lymphoma. Cancers 14:17, pages 4215.
Crossref
Yumeng Wu, Cheng Shen, Xinghui Wang, Wenjing Zhao, Yuanyuan Li, Xiao He, Yuanbin Chen, Jibin Liu, Xuming Wu & Aiguo Shen. (2022) Development and Validation of a Novel Circadian Rhythm-Related Signature to Predict the Prognosis of the Patients with Hepatocellular Carcinoma. BioMed Research International 2022, pages 1-19.
Crossref
Pei-Rong Qu, Zhi-Lin Jiang, Ping-Ping Song, Lan-Chun Liu, Mi Xiang & Jie Wang. (2022) Saponins and their derivatives: Potential candidates to alleviate anthracycline-induced cardiotoxicity and multidrug resistance. Pharmacological Research 182, pages 106352.
Crossref
Zhang Ye, Lun Gao, Jiayang Cai, Yixuan Wang, Yong Li, Shiao Tong, Tengfeng Yan, Qian Sun, Yangzhi Qi, Yang Xu, Hongxiang Jiang, Si Zhang, Linyao Zhao, Shenqi Zhang & Qianxue Chen. (2022) Esterase-responsive and size-optimized prodrug nanoparticles for effective intracranial drug delivery and glioblastoma treatment. Nanomedicine: Nanotechnology, Biology and Medicine 44, pages 102581.
Crossref
Saman Sargazi, Bazla Siddiqui, Maimoona Qindeel, Abbas Rahdar, Muhammad Bilal, Razieh Behzadmehr, Shekoufeh Mirinejad & Sadanand Pandey. (2022) Chitosan nanocarriers for microRNA delivery and detection: A preliminary review with emphasis on cancer. Carbohydrate Polymers 290, pages 119489.
Crossref
Jufang Guo, Xuelian Du & Chaolin Li. (2022) BAG family proteins contributes to autophagy-mediated multidrug resistance of tumor. Clinical and Translational Oncology 24:8, pages 1492-1500.
Crossref
Yitian Li, Jing Zhang, Huihui Zhou & Zhen Du. (2022) Anticancer effects of natural phytochemicals in anaplastic thyroid cancer (Review). Oncology Reports 48:3.
Crossref
Xinbo Yu, Changwei Huang, Jiyuan Liu, Xinyu Shi & Xiaodong Li. (2022) The significance of PAK4 in signaling and clinicopathology: A review. Open Life Sciences 17:1, pages 586-598.
Crossref
Yinghao Zheng, Yun Wang, Mengyu Xia, Ya Gao, Lan Zhang, Yanan Song & Cun Zhang. (2021) The combination of nanotechnology and traditional Chinese medicine (TCM) inspires the modernization of TCM: review on nanotechnology in TCM-based drug delivery systems. Drug Delivery and Translational Research 12:6, pages 1306-1325.
Crossref
Wei-liang Sun, Ling-yan He, Li Liang, Si-yu Liu, Jie Luo, Mei-ling Lv & Zheng-wen Cai. (2022) Ambra1 regulates apoptosis and chemosensitivity in breast cancer cells through the Akt-FoxO1-Bim pathway. Apoptosis 27:5-6, pages 329-341.
Crossref
Bernadette Xin Jie Tune, Maw Shin Sim, Chit Laa Poh, Rhanye Mac Guad, Choy Ker Woon, Iswar Hazarika, Anju Das, Subash C. B. Gopinath, Mariappan Rajan, Mahendran Sekar, Vetriselvan Subramaniyan, Neeraj Kumar Fuloria, Shivkanya Fuloria, Kalaivani Batumalaie & Yuan Seng Wu. (2022) Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors. Journal of Oncology 2022, pages 1-25.
Crossref
Sai Manogna Kotakadi, Deva Prasad Raju Borelli & John Sushma Nannepaga. (2022) Therapeutic Applications of Magnetotactic Bacteria and Magnetosomes: A Review Emphasizing on the Cancer Treatment. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Pingting Ye, Lei Feng, Shuo Shi & Chunyan Dong. (2022) The Mechanisms of lncRNA-Mediated Multidrug Resistance and the Clinical Application Prospects of lncRNAs in Breast Cancer. Cancers 14:9, pages 2101.
Crossref
Alexandra Triantafyllou, Maria Gazouli, Charalampos Theodoropoulos, Eleni Zografos, George C. Zografos & Nikolaos V. Michalopoulos. (2022) Exosomes in breast cancer management: Where do we stand? A literature review. Biology of the Cell 114:4, pages 109-122.
Crossref
Samar El-Kalyoubi, Fatimah Agili, Islam Adel & Mohamed A. Tantawy. (2022) Novel uracil derivatives depicted potential anticancer agents: In Vitro, molecular docking, and ADME study. Arabian Journal of Chemistry 15:4, pages 103669.
Crossref
Absarul Haque, Ghazanfar Ali Baig, Abdulelah Saleh Alshawli, Khalid Hussain Wali Sait, Bilal Bin Hafeez, Manish Kumar Tripathi, Badrah Saeed Alghamdi, Hani S. H. Mohammed Ali & Mahmood Rasool. (2022) Interaction Analysis of MRP1 with Anticancer Drugs Used in Ovarian Cancer: In Silico Approach. Life 12:3, pages 383.
Crossref
Qiwei Du, Zuguo Yuan, Xiaoling Huang, Yuqing Huang, Jie Zhang & Rongguo Li. (2021) miR-26b-5p suppresses chemoresistance in breast cancer by targeting serglycin. Anti-Cancer Drugs 33:3, pages 308-319.
Crossref
Xing Huang, Gang Zhang, Tianyu Tang, Xiang Gao & Tingbo Liang. (2022) One shoot, three birds: Targeting NEK2 orchestrates chemoradiotherapy, targeted therapy, and immunotherapy in cancer treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877:2, pages 188696.
Crossref
Nazeer Hussain Khan, Maria Mir, Lei Qian, Mahnoor Baloch, Muhammad Farhan Ali Khan, Asim-ur- Rehman, Ebenezeri Erasto Ngowi, Dong-Dong Wu & Xin-Ying Ji. (2022) Skin cancer biology and barriers to treatment: Recent applications of polymeric micro/nanostructures. Journal of Advanced Research 36, pages 223-247.
Crossref
Sepideh Mirzaei, Mohammad Hossein Gholami, Farid Hashemi, Amirhossein Zabolian, Mahdi Vasheghani Farahani, Kiavash Hushmandi, Ali Zarrabi, Aaron Goldman, Milad Ashrafizadeh & Gorka Orive. (2022) Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects. Drug Discovery Today 27:2, pages 436-455.
Crossref
Gangyang Wang, Lingling Cao, Yafei Jiang, Tao Zhang, Hongsheng Wang, Zhuoying Wang, Jing Xu, Min Mao, Yingqi Hua, Zhengdong Cai, Xiaojun Ma, Shuo Hu & Chenghao Zhou. (2022) Anlotinib Reverses Multidrug Resistance (MDR) in Osteosarcoma by Inhibiting P-Glycoprotein (PGP1) Function In Vitro and In Vivo. Frontiers in Pharmacology 12.
Crossref
Na Feng, Ying Liu, Xianglin Dai, Yingying Wang, Qiong Guo & Qing Li. (2022) Advanced applications of cerium oxide based nanozymes in cancer. RSC Advances 12:3, pages 1486-1493.
Crossref
Dimitrios Vagiannis, Yu Zhang, Youssif Budagaga, Eva Novotna, Adam Skarka, Sarah Kammerer, Jan-Heiner Küpper & Jakub Hofman. (2022) Alisertib shows negligible potential for perpetrating pharmacokinetic drug-drug interactions on ABCB1, ABCG2 and cytochromes P450, but acts as dual-activity resistance modulator through the inhibition of ABCC1 transporter. Toxicology and Applied Pharmacology 434, pages 115823.
Crossref
Antonella Icardi, Silvina L. Lompardia, Daniela L. Papademetrio, Paolo Rosales, Mariángeles Díaz, Matías A. Pibuel, Laura Alaniz & Elida Alvarez. 2022. The Extracellular Matrix and the Tumor Microenvironment. The Extracellular Matrix and the Tumor Microenvironment 161 196 .
Qi Xu, Qiuting Li, Zhe Yang, Piao Huang, Han Hu, Zhimin Mo, Zizhen Qin, Zushun Xu, Tianyou Chen & Shengli Yang. (2021) Lenvatinib and Cu 2− x S nanocrystals co-encapsulated in poly( d , l -lactide- co -glycolide) for synergistic chemo-photothermal therapy against advanced hepatocellular carcinoma . Journal of Materials Chemistry B 9:48, pages 9908-9922.
Crossref
Siliang Jiang, Yu Fu, Xinyang Zhang, Tong Yu, Bowen Lu & Juan Du. (2021) Research Progress of Carrier-Free Antitumor Nanoparticles Based on Phytochemicals. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Guo-Hua Li, Qiang Qu, Ting-Ting Qi, Xin-Qi Teng, Hai-Hong Zhu, Jiao-Jiao Wang, Qiong Lu & Jian Qu. (2021) Super-enhancers: a new frontier for epigenetic modifiers in cancer chemoresistance. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Milad Ashrafizadeh, Hossein Rafiei, Reza Mohammadinejad, Tahereh Farkhondeh & Saeed Samarghandian. (2021) Anti-tumor activity of resveratrol against gastric cancer: a review of recent advances with an emphasis on molecular pathways. Cancer Cell International 21:1.
Crossref
Jinzhu Zhao, Leilei Li, Zhijia Wang, Linlin Li, Mingjing He, Shuhua Han, Yalong Dong, Xiaojie Liu, Wen Zhao, Yu Ke & Cong Wang. (2021) Luteolin attenuates cancer cell stemness in PTX-resistant oesophageal cancer cells through mediating SOX2 protein stability. Pharmacological Research 174, pages 105939.
Crossref
Van Toan Nguyen, Quoc Trung Nguyen, Ngoc Thach Pham, Dinh Trung Nguyen, Tri Nhut Pham & Ngoc Quyen Tran. (2021) An in vitro investigation into targeted paclitaxel delivery nanomaterials based on chitosan-Pluronic P123-biotin copolymer for inhibiting human breast cancer cells. Journal of Drug Delivery Science and Technology 66, pages 102807.
Crossref
Sally Safwat, Rania M. Hathout, Rania A. Ishak & Nahed D. Mortada. (2021) Elaborated survey in the scope of nanocarriers engineering for boosting chemotherapy cytotoxicity: A meta-analysis study. International Journal of Pharmaceutics 610, pages 121268.
Crossref
Xin Yue, Wen-ying Wu, Ma Dong & Meng Guo. (2021) LncRNA MALAT1 promotes breast cancer progression and doxorubicin resistance via regulating miR-570–3p. Biomedical Journal 44:6, pages S296-S304.
Crossref
Zi‐Ning Lei, Qiu‐Xu Teng, Zhuo‐Xun Wu, Feng‐Feng Ping, Peng Song, John N.D. Wurpel & Zhe‐Sheng Chen. (2021) Overcoming multidrug resistance by knockout of ABCB1 gene using CRISPR/Cas9 system in SW620/Ad300 colorectal cancer cells. MedComm 2:4, pages 765-777.
Crossref
Shu-Ting Xu, Cheng Yang & Xiu-Ping Yan. (2021) Nanothorn Filter-Facilitated Online Cell Lysis for Rapid and Deep Intracellular Profiling by Single-Cell Mass Spectrometry. Analytical Chemistry 93:47, pages 15677-15686.
Crossref
Enping Chen, Ting Wang, Junmei Zhang, Xiang Zhou, Yafan Niu, Fu Liu, Yinan Zhong, Dechun Huang & Wei Chen. (2021) Mitochondrial Targeting and pH-Responsive Nanogels for Co-Delivery of Lonidamine and Paclitaxel to Conquer Drug Resistance. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Eleftheria Lakiotaki, Dimitrios Kanakoglou, Andromachi Pampalou, Eleni Karatrasoglou, Christina Piperi & Penelope Korkolopoulou. (2021) Dissecting the Role of Circular RNAs in Sarcomas with Emphasis on Osteosarcomas. Biomedicines 9:11, pages 1642.
Crossref
Jin Mo Ku, Se Hyang Hong, Hyo In Kim, Min Jeong Kim, Su-Jeong Ku, Kwang-Rok Bae, Hye Sook Seo, Yong Cheol Shin & Seong-Gyu Ko. (2021) SH003 overcomes drug resistance and immune checkpoints by inhibiting JAK-STAT3 signaling in MCF7/ADR cells. Phytomedicine Plus 1:4, pages 100111.
Crossref
Chen Chen, Yuying Guo, Yaxin Guo, Xiaoke Wu, Chaohua Si, Yanxin Xu, Qiaozhen Kang & Zhenqiang Sun. (2021) m6A Modification in Non-Coding RNA: The Role in Cancer Drug Resistance. Frontiers in Oncology 11.
Crossref
Patrícia Pereira, Arménio C. Serra & Jorge F.J. Coelho. (2021) Vinyl Polymer-based technologies towards the efficient delivery of chemotherapeutic drugs. Progress in Polymer Science 121, pages 101432.
Crossref
Lifeng Feng, Muchun Li, Xinyang Hu, Yiling Li, Liyuan Zhu, Miaoqin Chen, Qi Wei, Wenxia Xu, Qiyin Zhou, Weikai Wang, Dingwei Chen, Xian Wang & Hongchuan Jin. (2021) CK1δ stimulates ubiquitination‐dependent proteasomal degradation of ATF4 to promote chemoresistance in gastric Cancer. Clinical and Translational Medicine 11:10.
Crossref
Tiantian Tan, Jie Li, Ruhua Luo, Rongrong Wang, Liyan Yin, Mengmeng Liu, Yiying Zeng, Zhaowu Zeng & Tian Xie. (2021) Recent Advances in Understanding the Mechanisms of Elemene in Reversing Drug Resistance in Tumor Cells: A Review. Molecules 26:19, pages 5792.
Crossref
Elena V. Salimova & Lyudmila V. Parfenova. (2021) Synthesis and Biological Activity of Oximes, Amines, and Lactams of Fusidane Triterpenoids. ChemistrySelect 6:33, pages 8848-8854.
Crossref
Tingting Zou, Cheng Zeng, Junyan Qu, Xiaohua Yan & Zhenghong Lin. (2021) Rutaecarpine Increases Anticancer Drug Sensitivity in Drug-Resistant Cells through MARCH8-Dependent ABCB1 Degradation. Biomedicines 9:9, pages 1143.
Crossref
Suwichak Chaisit & Suree Jianmongkol. (2021) Apoptosis Inducing Activity of Rhinacanthin-C in Doxorubicin-Resistant Breast Cancer MCF-7 Cells. Biological and Pharmaceutical Bulletin 44:9, pages 1239-1246.
Crossref
Ya-Sheng Li, Shen Mao, Dong-Sheng Zhao, Can-Can Wang, Dan Zu, Xi Yang, Gui-Jun Liu, Si-Jia Wang, Bo Zhang, Xiao-Ze Bao, Xin-Yi Ye, Bin Wei, Zi-Ning Cui, Jian-Wei Chen & Hong Wang. (2021) Rational design of phenyl thiophene (pyridine) derivatives that overcome P-glycoprotein mediated MDR in MCF-7/ADR cell. Bioorganic Chemistry 114, pages 105075.
Crossref
Antoine Goisnard, Pierre Daumar, Clémence Dubois, Corinne Aubel, Manon Roux, Marie Depresle, Jean Gauthier, Bernard Vidalinc, Frédérique Penault-Llorca, Emmanuelle Mounetou & Mahchid Bamdad. (2021) LightSpot®-FL-1 Fluorescent Probe: An Innovative Tool for Cancer Drug Resistance Analysis by Direct Detection and Quantification of the P-glycoprotein (P-gp) on Monolayer Culture and Spheroid Triple Negative Breast Cancer Models. Cancers 13:16, pages 4050.
Crossref
Hua-yang Fan, Zhuo-li Zhu, Hong-chun Xian, Hao-fan Wang, Bing-jun Chen, Ya-Jie Tang, Ya-ling Tang & Xin-hua Liang. (2021) Insight Into the Molecular Mechanism of Podophyllotoxin Derivatives as Anticancer Drugs. Frontiers in Cell and Developmental Biology 9.
Crossref
Candice Mckertish & Veysel Kayser. (2021) Advances and Limitations of Antibody Drug Conjugates for Cancer. Biomedicines 9:8, pages 872.
Crossref
Suree Jianmongkol. 2021. Advances in Precision Medicine Oncology. Advances in Precision Medicine Oncology.
Tao Liu, Rongmu Xia, Chenmeng Li, Xiaocong Chen, Xuemin Cai & Wengang Li. (2021) mRNA expression level of CDH2, LEP, POSTN, TIMP1 and VEGFC modulates 5‑fluorouracil resistance in colon cancer cells . Experimental and Therapeutic Medicine 22:3.
Crossref
Khadijeh Jamialahmadi, Fatemeh Zahedipour & Gholamreza Karimi. (2021) The role of microRNAs on doxorubicin drug resistance in breast cancer. Journal of Pharmacy and Pharmacology 73:8, pages 997-1006.
Crossref
Guandi He, Weijun Tian, Lijun Qin, Lulu Meng, Danxia Wu, Yun Huang, Dandan Li, Degang Zhao & Tengbing He. (2021) Identification of novel heavy metal detoxification proteins in Solanum tuberosum: Insights to improve food security protection from metal ion stress. Science of The Total Environment 779, pages 146197.
Crossref
Zibo Li, Lin Zhang, Dan Liu & Caiyan Wang. (2021) Ceramide glycosylation and related enzymes in cancer signaling and therapy. Biomedicine & Pharmacotherapy 139, pages 111565.
Crossref
Guorong Cheng, Zifeng Pi, Xiaoyu Zhuang, Zhong Zheng, Shu Liu, Zhiqiang Liu & Fengrui Song. (2021) The effects and mechanisms of aloe‐emodin on reversing adriamycin‐induced resistance of MCF ‐7/ ADR cells . Phytotherapy Research 35:7, pages 3886-3897.
Crossref
Brian Kawahara, Kym F. Faull, Carla Janzen & Pradip K. Mascharak. (2021) Carbon Monoxide Inhibits Cytochrome P450 Enzymes CYP3A4/2C8 in Human Breast Cancer Cells, Increasing Sensitivity to Paclitaxel. Journal of Medicinal Chemistry 64:12, pages 8437-8446.
Crossref
Maolin Ge, Qiongyu Xu, Ting Kang, Dan Li, Ruiheng Wang, Zhihong Chen, Shufeng Xie, Wenbin Wang & Han Liu. (2021) Deubiquitinating enzyme inhibitor alleviates cyclin A1‐mediated proteasome inhibitor tolerance in mixed‐lineage leukemia. Cancer Science 112:6, pages 2287-2298.
Crossref
Ming Wu, Yujie Zhao, Nanxi Peng, Zuo Tao & Bo Chen. (2021) Identification of chemoresistance-associated microRNAs and hub genes in breast cancer using bioinformatics analysis. Investigational New Drugs 39:3, pages 705-712.
Crossref
Nirmala Tilija Pun & Chul-Ho Jeong. (2021) Statin as a Potential Chemotherapeutic Agent: Current Updates as a Monotherapy, Combination Therapy, and Treatment for Anti-Cancer Drug Resistance. Pharmaceuticals 14:5, pages 470.
Crossref
Wookyeom Yang, Dasol Kim, Dae Kyoung Kim, Kyung Un Choi, Dong Soo Suh & Jae Ho Kim. (2021) Therapeutic Strategies for Targeting Ovarian Cancer Stem Cells. International Journal of Molecular Sciences 22:10, pages 5059.
Crossref
Run-Ze Chen, Fei Yang, Min Zhang, Zhi-Gang Sun & Nan Zhang. (2021) Cellular and Molecular Mechanisms of Pristimerin in Cancer Therapy: Recent Advances. Frontiers in Oncology 11.
Crossref
Masood Alam Khan. (2021) Targeted Drug Delivery Using Tuftsin-bearing Liposomes: Implications in the Treatment of Infectious Diseases and Tumors. Current Drug Targets 22:7, pages 770-778.
Crossref
Siyao Dong, Chengyan Song, Baocui Qi, Xiaochen Jiang, Lu Liu & Yan Xu. (2021) Strongly preserved modules between cancer tissue and cell line contribute to drug resistance analysis across multiple cancer types. Genomics 113:3, pages 1026-1036.
Crossref
Roman V. Lenchine, Sushma R. Rao, Xuemin Wang, Danielle Meiwen Fang & Christopher G. Proud. (2021) Elongation factor eEF2 kinase and autophagy jointly promote survival of cancer cells. Biochemical Journal 478:8, pages 1547-1569.
Crossref
Raúl Ortíz, Francisco Quiñonero, Beatriz García-Pinel, Marco Fuel, Cristina Mesas, Laura Cabeza, Consolación Melguizo & Jose Prados. (2021) Nanomedicine to Overcome Multidrug Resistance Mechanisms in Colon and Pancreatic Cancer: Recent Progress. Cancers 13:9, pages 2058.
Crossref
Ting Wang, Jingjing Dong, Xu Yuan, Haotian Wen, Linguangjin Wu, Jianwen Liu, Hua Sui & Wanli Deng. (2021) A New Chalcone Derivative C49 Reverses Doxorubicin Resistance in MCF-7/DOX Cells by Inhibiting P-Glycoprotein Expression. Frontiers in Pharmacology 12.
Crossref
Yushu Huang, Yang He, Xiaoyan Xia, Hao Quan & Jiahui Yu. (2021) Phenylboronic acid-functionalized co-delivery micelles with synergistic effect and down-regulation of HIF-1alpha to overcome multidrug resistance. Journal of Drug Delivery Science and Technology 62, pages 102346.
Crossref
Balaram Ghosh & Swati Biswas. (2021) Polymeric micelles in cancer therapy: State of the art. Journal of Controlled Release 332, pages 127-147.
Crossref
Ya-Sheng Li, Xi Yang, Dong-Sheng Zhao, Yue Cai, Zhi Huang, Rui Wu, Si-Jia Wang, Gui-Jun Liu, Jian Wang, Xiao-Ze Bao, Xin-Yi Ye, Bin Wei, Zi-Ning Cui & Hong Wang. (2021) Design, synthesis and bioactivity study on 5-phenylfuran derivatives as potent reversal agents against P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell. European Journal of Medicinal Chemistry 216, pages 113336.
Crossref
Anna Choromańska, Agnieszka Chwiłkowska, Julita Kulbacka, Dagmara Baczyńska, Nina Rembiałkowska, Anna Szewczyk, Olga Michel, Agnieszka Gajewska-Naryniecka, Dawid Przystupski & Jolanta Saczko. (2021) Modifications of Plasma Membrane Organization in Cancer Cells for Targeted Therapy. Molecules 26:7, pages 1850.
Crossref
Chao Dong, Jiao Wu, Yin Chen, Jianyun Nie & Ceshi Chen. (2021) Activation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer. Frontiers in Pharmacology 12.
Crossref
Ming Li & Xiaoying Zhang. (2021) BRAF Mutations and Resistance of Non-Small Cell Lung Cancer to BRAF-Targeted Therapies Using Liquid Biopsy. Asia-Pacific Journal of Oncology Nursing 8:2, pages 110-111.
Crossref
Prarthna Yadav, Harshita Mishra, Manju Nagpal & Geeta Aggarwal. (2021) Expanding Opportunities in Treatment of Leukemia by Solid Lipid Nanoparticles. Letters in Drug Design & Discovery 18:3, pages 212-221.
Crossref
Danfeng Xue, Xiongming Zhou & Jiaxuan Qiu. (2021) Cytotoxicity mechanisms of plumbagin in drug-resistant tongue squamous cell carcinoma. Journal of Pharmacy and Pharmacology 73:1, pages 98-109.
Crossref
Maolin Ge, Zhi Qiao, Yan Kong, Hongyu Liang, Yan Sun, Hui Lu, Zhenshu Xu & Han Liu. (2020) Modulating proteasome inhibitor tolerance in multiple myeloma: an alternative strategy to reverse inevitable resistance. British Journal of Cancer 124:4, pages 770-776.
Crossref
María Paula Ceballos, Antonella Angel, Carla Beatriz Delprato, Verónica Inés Livore, Anabela Cecilia Ferretti, Alvaro Lucci, Carla Gabriela Comanzo, María de Luján Alvarez, Ariel Darío Quiroga, Aldo Domingo Mottino & María Cristina Carrillo. (2021) Sirtuin 1 and 2 inhibitors enhance the inhibitory effect of sorafenib in hepatocellular carcinoma cells. European Journal of Pharmacology 892, pages 173736.
Crossref
Xuehua Luo, Huijun Xie, Li Han, Qiaoming Zhong, Meng Xu & Ling Jin. (2021) Integrated Network Pharmacology and Molecular Docking to Reveal the Mechanism of Tetrandrine in Tumor Chemoresistance. Oncologie 23:3, pages 425-438.
Crossref
Yanxia Zhao & Weifa Zheng. (2021) Deciphering the antitumoral potential of the bioactive metabolites from medicinal mushroom Inonotus obliquus. Journal of Ethnopharmacology 265, pages 113321.
Crossref
Ruxue Jia, Hu Zhao & Shuiliang Wang. 2021. Tumor Microenvironment. Tumor Microenvironment 1 29 .
Hang Zhang, Haiwei Xu, Charles R. AshbyJr.Jr., Yehuda G. Assaraf, Zhe‐Sheng Chen & Hong‐Min Liu. (2020) Chemical molecular‐based approach to overcome multidrug resistance in cancer by targeting P‐glycoprotein (P‐gp). Medicinal Research Reviews 41:1, pages 525-555.
Crossref
Xinhua Xi, Yongzheng Bao, Yangfan Zhou, Yu Chen, Xueren Zhong, Junjian Liao, Jun Zhou, Sitao Xu, Ziye Cao, Konghe Hu, Yongyu Hu, Xiaolong He, Longze Zhou, Hongsheng Lin & Qiang Wu. (2020) Oncogenic gene TRIM10 confers resistance to cisplatin in osteosarcoma cells and activates the NF‐κB signaling pathway. Cell Biology International 45:1, pages 74-82.
Crossref
Qie Guo, Xiao Li, Meng-Na Cui, Jia-Lin Sun, Hong-Yan Ji, Bei-Bei Ni & Mei-Xing Yan. (2020) CD13: A Key Player in Multidrug Resistance in Cancer Chemotherapy. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 28:5, pages 533-540.
Crossref
Peng Yang, Wen Liu, Rong Fu, Guo-bin Ding, Sajid Amin & Zhuoyu Li. (2020) Cucurbitacin E Chemosensitizes Colorectal Cancer Cells via Mitigating TFAP4/Wnt/β-Catenin Signaling. Journal of Agricultural and Food Chemistry 68:48, pages 14148-14160.
Crossref
Yuanming Jing, Wenqing Liang, Jian Liu, Lin Zhang, Jianguo Wei, Jianhui Yang, Yu Zhang & Zongliang Huang. (2020) Autophagy-mediating microRNAs in cancer chemoresistance. Cell Biology and Toxicology 36:6, pages 517-536.
Crossref
Maria Papatsirou, Pinelopi I Artemaki, Andreas Scorilas & Christos K Kontos. (2020) The role of circular RNAs in therapy resistance of patients with solid tumors. Personalized Medicine 17:6, pages 469-490.
Crossref
Maryam Akbarzadeh, Shabnam Akbarzadeh & Maryam Majidinia. (2020) Targeting Notch signaling pathway as an effective strategy in overcoming drug resistance in ovarian cancer. Pathology - Research and Practice 216:11, pages 153158.
Crossref
Katja Zappe & Margit Cichna-Markl. (2020) Aberrant DNA Methylation of ABC Transporters in Cancer. Cells 9:10, pages 2281.
Crossref
Xing-Duo Dong, Meng Zhang, Xiubin Ma, Jing-Quan Wang, Zi-Ning Lei, Qiu-Xu Teng, Yi-Dong Li, Lusheng Lin, Weiguo Feng & Zhe-Sheng Chen. (2020) Bruton’s Tyrosine Kinase (BTK) Inhibitor RN486 Overcomes ABCB1-Mediated Multidrug Resistance in Cancer Cells. Frontiers in Cell and Developmental Biology 8.
Crossref
Lili Duan, Jiaojiao Ma, Wanli Yang, Lu Cao, Xiaoqian Wang, Liaoran Niu, Yiding Li, Wei Zhou, Yujie Zhang, Jinqiang Liu, Hongwei Zhang, Qingchuan Zhao, Liu Hong & Daiming Fan. (2020) EI24 Inhibits Cell Proliferation and Drug Resistance of Esophageal Squamous Cell Carcinoma. Frontiers in Oncology 10.
Crossref
Lei GaoPeiran ZhaoYang LiDawei YangPing HuLianzhi LiYufeng ChengHengchen Yao. (2020) Reversal of P-glycoprotein-mediated multidrug resistance by novel curcumin analogues in paclitaxel-resistant human breast cancer cells. Biochemistry and Cell Biology 98:4, pages 484-491.
Crossref
Zhuo‐Xun Wu, Yuqi Yang, Guangsuo Wang, Jing‐Quan Wang, Qiu‐Xu Teng, Lingling Sun, Zi‐Ning Lei, Lizhu Lin, Zhe‐Sheng Chen & Chang Zou. (2020) Dual TTK/CLK2 inhibitor, CC‐671, selectively antagonizes ABCG2‐mediated multidrug resistance in lung cancer cells. Cancer Science 111:8, pages 2872-2882.
Crossref
Meng Zhang, Xuan-Yu Chen, Xing-Duo Dong, Jing-Quan Wang, Weiguo Feng, Qiu-Xu Teng, Qingbin Cui, Jing Li, Xiang-Qi Li & Zhe-Sheng Chen. (2020) NVP-CGM097, an HDM2 Inhibitor, Antagonizes ATP-Binding Cassette Subfamily B Member 1-Mediated Drug Resistance. Frontiers in Oncology 10.
Crossref
Yi-Dong Li, Yong Mao, Xing-Duo Dong, Zi-Ning Lei, Yuqi Yang, Lizhu Lin, Charles R. AshbyJr.Jr., Dong-Hua Yang, Ying-Fang Fan & Zhe-Sheng Chen. (2020) Methyl-Cantharidimide (MCA) Has Anticancer Efficacy in ABCB1- and ABCG2-Overexpressing and Cisplatin Resistant Cancer Cells. Frontiers in Oncology 10.
Crossref
Weiguo Feng, Meng Zhang, Zhuo-Xun Wu, Jing-Quan Wang, Xing-Duo Dong, Yuqi Yang, Qiu-Xu Teng, Xuan-Yu Chen, Qingbin Cui & Dong-Hua Yang. (2020) Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells. Frontiers in Oncology 10.
Crossref
Hairui Wang & Yongzhuo Huang. (2020) Combination therapy based on nano codelivery for overcoming cancer drug resistance. Medicine in Drug Discovery 6, pages 100024.
Crossref
Pei Zhang, Surong Zhao, Xingyue Lu, Zongfen Shi, Hao Liu & Bing Zhu. (2020) Metformin enhances the sensitivity of colorectal cancer cells to cisplatin through ROS-mediated PI3K/Akt signaling pathway. Gene 745, pages 144623.
Crossref
Yao Ma, Dawei Yin, Jingjia Ye, Xiduan Wei, Yameng Pei, Xueyuan Li, Guangxu Si, Xuan-Yu Chen, Zhe-Sheng Chen, Yi Dong, Feng Zou, Wei Shi, Qianqian Qiu, Hai Qian & Gang Liu. (2020) Discovery of Potent Inhibitors against P-Glycoprotein-Mediated Multidrug Resistance Aided by Late-Stage Functionalization of a 2-(4-(Pyridin-2-yl)phenoxy)pyridine Analogue. Journal of Medicinal Chemistry 63:10, pages 5458-5476.
Crossref
Absarul Haque, Khalid Hussain Wali Sait, Qamre Alam, Mohammad Zubair Alam, Nisreen Anfinan, Abdul Wahab Noor Wali & Mahmood Rasool. (2020) MDR1 Gene Polymorphisms and Its Association With Expression as a Clinical Relevance in Terms of Response to Chemotherapy and Prognosis in Ovarian Cancer. Frontiers in Genetics 11.
Crossref
Danuta Kuzajewska, Agata Wszołek, Wojciech Żwierełło, Lucyna Kirczuk & Agnieszka Maruszewska. (2020) Magnetotactic Bacteria and Magnetosomes as Smart Drug Delivery Systems: A New Weapon on the Battlefield with Cancer?. Biology 9:5, pages 102.
Crossref
Hongyu Tao, Ling Zuo, Huanli Xu, Cong Li, Gan Qiao, Mingyue Guo & Xiukun Lin. (2020) Alkaloids as Anticancer Agents: A Review of Chinese Patents in Recent 5 Years. Recent Patents on Anti-Cancer Drug Discovery 15:1, pages 2-13.
Crossref
Yuqi Yang, Ning Ji, Qiu-Xu Teng, Chao-Yun Cai, Jing-Quan Wang, Zhuo-Xun Wu, Zi-Ning Lei, Sabrina Lusvarghi, Suresh V. Ambudkar & Zhe-Sheng Chen. (2020) Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro. Frontiers in Oncology 10.
Crossref
Zhuo-Xun Wu, Zheng Peng, Yuqi Yang, Jing-Quan Wang, Qiu-Xu Teng, Zi-Ning Lei, Yi-Ge Fu, Ketankumar Patel, Lili Liu, Lizhu Lin, Chang Zou & Zhe-Sheng Chen. (2020) M3814, a DNA-PK Inhibitor, Modulates ABCG2-Mediated Multidrug Resistance in Lung Cancer Cells. Frontiers in Oncology 10.
Crossref
Xiaoyu Zhang, Weibin Chen, Jie Bai, Lijun Jin, Xiaoning Kang, Hui Zhang & Zunyi Wang. (2020) Pluronic P123 modified nano micelles loaded with doxorubicin enhanced tumor-suppressing effect on drug-resistant breast cancer cells. Aging 12:9, pages 8289-8300.
Crossref
Liyun Luo, Jianlei Zhang, Hailin Tang, Dongfeng Zhai, Danqing Huang, Li Ling, Xiaorong Wang, Ting Liu, Qiong Zhang, Zhijie Zhang, Zhimin He & Guopei Zheng. (2020) LncRNA SNORD3A specifically sensitizes breast cancer cells to 5-FU by sponging miR-185-5p to enhance UMPS expression. Cell Death & Disease 11:5.
Crossref
Yifan Guo, Bin Li, Xu Yan, Xinming Shen, Juan Ma, Sijin Liu & Daoqiang Zhang. (2020) Bisphenol A and polychlorinated biphenyls enhance the cancer stem cell properties of human ovarian cancer cells by activating the WNT signaling pathway. Chemosphere 246, pages 125775.
Crossref
Francisco V.C. Mello, Gabriela N. de Moraes, Raquel C. Maia, Jennifer Kyeremateng, Surtaj Hussain Iram & Ralph Santos-Oliveira. (2020) The Effect of Nanosystems on ATP-Binding Cassette Transporters: Understanding the Influence of Nanosystems on Multidrug Resistance Protein-1 and P-glycoprotein. International Journal of Molecular Sciences 21:7, pages 2630.
Crossref
Maolin Ge, Zhi Qiao, Yan Kong, Hui Lu & Han Liu. (2020) Exosomes mediate intercellular transfer of non–autonomous tolerance to proteasome inhibitors in mixed‐lineage leukemia. Cancer Science 111:4, pages 1279-1290.
Crossref
Qiang Gao, Xiu-xiu Li, Yi-ming Xu, Jin-zhao Zhang, Shi-di Rong, Yan-qing Qin & Jing Fang. (2020) IRE1α-targeting downregulates ABC transporters and overcomes drug resistance of colon cancer cells. Cancer Letters 476, pages 67-74.
Crossref
Shengliang Liao, Xiaoping Rao, Minggui Shen, Hongyan Si, Jie Song, Shibin Shang & Zhanqian Song. (2020) New Hybrids Derived from the Natural Compound (-)-β-Pinene and Amides or Acylthioureas as Antitumor Agents. Letters in Drug Design & Discovery 17:3, pages 271-284.
Crossref
Danfeng Xue, Shu-Ting Pan, Xiongming Zhou, Fangfei Ye, Qun Zhou, Fanzhe Shi, Fei He, Hui Yu & Jiaxuan Qiu. (2020) Plumbagin Enhances the Anticancer Efficacy of Cisplatin by Increasing Intracellular ROS in Human Tongue Squamous Cell Carcinoma. Oxidative Medicine and Cellular Longevity 2020, pages 1-21.
Crossref
Jian Zhao, Xingyang Xue, Wenfan Fu, Lu Dai, Zeyong Jiang, Shengpeng Zhong, Boyun Deng & Jun Yin. (2020) Epigenetic activation of FOXF1 confers cancer stem cell properties to cisplatin‑resistant non‑small cell lung cancer. International Journal of Oncology.
Crossref
Zhuo-Xun Wu, Yuqi Yang, Qiu-Xu Teng, Jing-Quan Wang, Zi-Ning Lei, Jing-Qiu Wang, Sabrina Lusvarghi, Suresh Ambudkar, Dong-Hua Yang & Zhe-Sheng Chen. (2020) Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug Resistance. Cancers 12:1, pages 186.
Crossref
Yaron Ilan & Zachary Spigelman. (2020) Establishing patient-tailored variability-based paradigms for anti-cancer therapy: Using the inherent trajectories which underlie cancer for overcoming drug resistance. Cancer Treatment and Research Communications 25, pages 100240.
Crossref
Lin Chang, Yulan Hou, Lili Zhu, Zhixue Wang, Guotao Chen, Chengfeng Shu & Yali Liu. (2020) Veliparib overcomes multidrug resistance in liver cancer cells. Biochemical and Biophysical Research Communications 521:3, pages 596-602.
Crossref
Livia Neves Borgheti-Cardoso, Juliana Santos Rosa Viegas, Ana Vitoria Pupo Silvestrini, Angelo Luis Caron, Fabiola Garcia Praça, Marcelo Kravicz & Maria Vitória Lopes Badra Bentley. (2020) Nanotechnology approaches in the current therapy of skin cancer. Advanced Drug Delivery Reviews 153, pages 109-136.
Crossref
Frederik Otzen Bagger & Victoria Probst. 2020. Single-cell Sequencing and Methylation. Single-cell Sequencing and Methylation 175 193 .
Morteza Ghandadi, Reza Valadan, Hamidreza Mohammadi, Javad Akhtari, Shabanali Khodashenas & Sorour Ashari. (2019) Wnt-β-catenin Signaling Pathway, the Achilles' Heels of Cancer Multidrug Resistance. Current Pharmaceutical Design 25:39, pages 4192-4207.
Crossref
Ruipu Sun, Ying Ying, Zhimin Tang, Ting Liu, Fuli Shi, Huixia Li, Taichen Guo, Shibo Huang & Ren Lai. (2019) The Emerging Role of the SLCO1B3 Protein in Cancer Resistance. Protein & Peptide Letters 27:1, pages 17-29.
Crossref
Yueqing Chen, Waiying Yvonne Tang, Xinyuan Tong & Hongbin Ji. (2019) Pathological transition as the arising mechanism for drug resistance in lung cancer. Cancer Communications 39:1, pages 53.
Crossref
Lu Jiang, Pan Wang, Ying-Jian Sun & Yi-Jun Wu. (2019) Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Anton V. Kolotaev, Karine R. Matevosyan, Vasiliy N. Osipov & Derenik S. Khachatryan. (2019) Synthesis of new quinazoline-containing hydroxamic acids as potential HDAC/VEGFR inhibitors. Unusual rearrangements with pyrrolidone ring opening and dehydration of 3-N-hydroxyquinazoline fragment containing tetracycles. Tetrahedron Letters 60:51, pages 151315.
Crossref
Innocensia Mokgohlwe Mangoato, Chandrashekara Puthanapura Mahadevappa & Motlalepula Gilbert Matsabisa. (2019) Cannabis sativa L. Extracts can reverse drug resistance in colorectal carcinoma cells in vitro. Synergy 9, pages 100056.
Crossref
Monica Marzagalli, Michela Raimondi, Fabrizio Fontana, Marina Montagnani Marelli, Roberta M. Moretti & Patrizia Limonta. (2019) Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications. Seminars in Cancer Biology 59, pages 221-235.
Crossref
Wenji Zhang, Wenjuan Zhang, Lingli Sun, Limin Xiang, Xingfei Lai, Qiuhua Li & Shili Sun. (2019) The effects and mechanisms of epigallocatechin-3-gallate on reversing multidrug resistance in cancer. Trends in Food Science & Technology 93, pages 221-233.
Crossref
Philipp Ottis, Chiara Palladino, Phillip Thienger, Adrian Britschgi, Christian Heichinger, Marco Berrera, Alice Julien-Laferriere, Filip Roudnicky, Tony Kam-Thong, James R. Bischoff, Bruno Martoglio & Piergiorgio Pettazzoni. (2019) Cellular Resistance Mechanisms to Targeted Protein Degradation Converge Toward Impairment of the Engaged Ubiquitin Transfer Pathway. ACS Chemical Biology.
Crossref
Ryohei Maruhashi, Hiroaki Eguchi, Risa Akizuki, Shohei Hamada, Takumi Furuta, Toshiyuki Matsunaga, Satoshi Endo, Kenji Ichihara & Akira Ikari. (2019) Chrysin enhances anticancer drug-induced toxicity mediated by the reduction of claudin-1 and 11 expression in a spheroid culture model of lung squamous cell carcinoma cells. Scientific Reports 9:1.
Crossref
Dongmei Fan, Linlin Jiang, Yuewen Song, Shiqi Bao, Yuanyuan Yang, Xiangfei Yuan, Yongsu Zhen, Ming Yang & Dongsheng Xiong. (2019) An Engineered Fusion Protein Anti-CD19(Fab)-LDM Effectively Inhibits ADR-Resistant B Cell Lymphoma. Frontiers in Oncology 9.
Crossref
Ana P. Francisco, Eduarda Mendes, Ana R. Santos & Maria J. Perry. (2019) Anticancer Triazenes: from Bioprecursors to Hybrid Molecules. Current Pharmaceutical Design 25:14, pages 1623-1642.
Crossref
Li Jia, Nan Jia, Yan Gao, Haiyang Hu, Xiuli Zhao, Dawei Chen & Mingxi Qiao. (2019) Multi-Modulation of Doxorubicin Resistance in Breast Cancer Cells by Poly(l-histidine)-Based Multifunctional Micelles. Pharmaceutics 11:8, pages 385.
Crossref
Elnaz Abbasifarid, Sayed Mahmoud Sajjadi-Jazi, Maryam Beheshtian, Hilda Samimi, Bagher Larijani & Vahid Haghpanah. (2019) The Role of ATP-Binding Cassette Transporters in the Chemoresistance of Anaplastic Thyroid Cancer: A Systematic Review. Endocrinology 160:8, pages 2015-2023.
Crossref
Amit Kumar & Vikas Jaitak. (2019) Natural products as multidrug resistance modulators in cancer. European Journal of Medicinal Chemistry 176, pages 268-291.
Crossref
Zhuo-Xun Wu, Qiu-Xu Teng, Chao-Yun Cai, Jing-Quan Wang, Zi-Ning Lei, Yuqi Yang, Ying-Fang Fan, Jian-Ye Zhang, Jun Li & Zhe-Sheng Chen. (2019) Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cells. Biochemical Pharmacology 166, pages 120-127.
Crossref
Yue Pan, Yunqiu Zhang, Qing Chen, Xufeng Tao, Jianzhou Liu & Gary Guishan Xiao. (2019) CTAB Enhances Chemo-Sensitivity Through Activation of AMPK Signaling Cascades in Breast Cancer. Frontiers in Pharmacology 10.
Crossref
Ning Ji, Yuqi Yang, Chao-Yun Cai, Jing-Quan Wang, Zi-Ning Lei, Zhuo-Xun Wu, Qingbin Cui, Dong-Hua Yang, Zhe-Sheng Chen & Dexin Kong. (2019) Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an in vitro Study. Frontiers in Oncology 9.
Crossref
Hailing Duan, Zaixing Yang, Lan Liang & Xiangdong Zhou. (2019) CA916798 gene expression is associated with multidrug resistance and predicts progression‑free survival in patients with lung cancer. Oncology Letters.
Crossref
Ahmet Altay, Aysun Kılıc Suloglu, Gulcın Sagdıcoglu Celep, Guldenız Selmanoglu & Faruk Bozoglu. (2019) Anatolıan sage Salvıa frutıcosa ınhıbıts cytosolıc glutathıone-s-transferase actıvıty and colon cancer cell prolıferatıon. Journal of Food Measurement and Characterization 13:2, pages 1390-1399.
Crossref
María Paula Ceballos, Juan Pablo Rigalli, Lucila Inés Ceré, Mariana Semeniuk, Viviana Alicia Catania & María Laura Ruiz. (2019) ABC Transporters: Regulation and Association with Multidrug Resistance in Hepatocellular Carcinoma and Colorectal Carcinoma. Current Medicinal Chemistry 26:7, pages 1224-1250.
Crossref
Yan Gao, Li Jia, Qi Wang, Haiyang Hu, Xiuli Zhao, Dawei Chen & Mingxi Qiao. (2019) pH/Redox Dual-Responsive Polyplex with Effective Endosomal Escape for Codelivery of siRNA and Doxorubicin against Drug-Resistant Cancer Cells. ACS Applied Materials & Interfaces 11:18, pages 16296-16310.
Crossref
Zhu Kun‐Peng, Zhang Chun‐Lin, Ma Xiao‐Long & Zhang Lei. (2018) Fibronectin‐1 modulated by the long noncoding RNA OIP5‐AS1/miR‐200b‐3p axis contributes to doxorubicin resistance of osteosarcoma cells. Journal of Cellular Physiology 234:5, pages 6927-6939.
Crossref
Aynaz Mihanfar, Javad Aghazadeh Attari, Iraj Mohebbi, Maryam Majidinia, Mojtaba Kaviani, Mehdi Yousefi & Bahman Yousefi. (2018) Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance. Journal of Cellular Physiology 234:4, pages 3238-3253.
Crossref
Laura Bayón-Cordero, Itziar Alkorta & Lide Arana. (2019) Application of Solid Lipid Nanoparticles to Improve the Efficiency of Anticancer Drugs. Nanomaterials 9:3, pages 474.
Crossref
Guang Huang, Jin-Yun Dong, Qi-Jing Zhang, Qing-Qing Meng, Hui-Ran Zhao, Bao-Quan Zhu & Shao-Shun Li. (2019) Discovery and synthesis of sulfur-containing 6-substituted 5,8-dimethoxy-1,4-naphthoquinone oxime derivatives as new and potential anti-MDR cancer agents. European Journal of Medicinal Chemistry 165, pages 160-171.
Crossref
Jingyi Yan, Didi Chen, Xiaolei Chen, Xuecheng Sun, Qiantong Dong, Changyuan Hu, Feng Zhou & Wei Chen. (2019) Downregulation of lncRNA CCDC26 contributes to imatinib resistance in human gastrointestinal stromal tumors through IGF-1R upregulation. Brazilian Journal of Medical and Biological Research 52:6.
Crossref
Ning Ji, Yuqi Yang, Chao-Yun Cai, Zi-Ning Lei, Jing-Quan Wang, Pranav Gupta, Suneet Shukla, Suresh V. Ambudkar, Dexin Kong & Zhe-Sheng Chen. (2019) Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells. Cancer Letters 440-441, pages 82-93.
Crossref
Anna Palko-Łabuz, Kamila Środa-Pomianek, Olga Wesołowska, Edyta Kostrzewa-Susłow, Anna Uryga & Krystyna Michalak. (2019) MDR reversal and pro-apoptotic effects of statins and statins combined with flavonoids in colon cancer cells. Biomedicine & Pharmacotherapy 109, pages 1511-1522.
Crossref
Mun Fai Loke & Aimi Hanafi. 2019. Encyclopedia of Bioinformatics and Computational Biology. Encyclopedia of Bioinformatics and Computational Biology 926 931 .
Ning Ji, Yuqi Yang, Zi-Ning Lei, Chao-Yun Cai, Jing-Quan Wang, Pranav Gupta, Xiaomeng Xian, Dong-Hua Yang, Dexin Kong & Zhe-Sheng Chen. (2018) Ulixertinib (BVD-523) antagonizes ABCB1- and ABCG2-mediated chemotherapeutic drug resistance. Biochemical Pharmacology 158, pages 274-285.
Crossref
Ning Ji, Yuqi Yang, Chao-Yun Cai, Zi-Ning Lei, Jing-Quan Wang, Pranav Gupta, Qiu-Xu Teng, Zhe-Sheng Chen, Dexin Kong & Dong-Hua Yang. (2018) VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters. Frontiers in Pharmacology 9.
Crossref
Hiroaki Eguchi, Risa Akizuki, Ryohei Maruhashi, Mitsutoshi Tsukimoto, Takumi Furuta, Toshiyuki Matsunaga, Satoshi Endo & Akira Ikari. (2018) Increase in resistance to anticancer drugs involves occludin in spheroid culture model of lung adenocarcinoma A549 cells. Scientific Reports 8:1.
Crossref
Wei Zhang, Ying-Fang Fan, Chao-Yun Cai, Jing-Quan Wang, Qiu-Xu Teng, Zi-Ning Lei, Leli Zeng, Pranav Gupta & Zhe-Sheng Chen. (2018) Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells. Frontiers in Pharmacology 9.
Crossref
Xing Zheng & Hongxia Li. (2018) TKTL1 modulates the response of paclitaxel-resistant human ovarian cancer cells to paclitaxel. Biochemical and Biophysical Research Communications 503:2, pages 572-579.
Crossref
Bo Wang, Li-Ying Ma, Jing-Quan Wang, Zi-Ning Lei, Pranav Gupta, Yuan-Di Zhao, Zhong-Hua Li, Ying Liu, Xin-Hui Zhang, Ya-Nan Li, Bing Zhao, Zhe-Sheng Chen & Hong-Min Liu. (2018) Discovery of 5-Cyano-6-phenylpyrimidin Derivatives Containing an Acylurea Moiety as Orally Bioavailable Reversal Agents against P-Glycoprotein-Mediated Mutidrug Resistance. Journal of Medicinal Chemistry 61:14, pages 5988-6001.
Crossref
Tiantian Qin, Weihua Liu, Junfeng Huo, Leilei Li, Xueyan Zhang, Xiaoli Shi, Jinlei Zhou & Cong Wang. (2018) SIRT1 expression regulates the transformation of resistant esophageal cancer cells via the epithelial-mesenchymal transition. Biomedicine & Pharmacotherapy 103, pages 308-316.
Crossref
Guan-Nan Zhang, Yun-Kai Zhang, Yi-Jun Wang, Pranav Gupta, Charles R. AshbyJr.Jr., Saeed Alqahtani, Tongjin Deng, Susan E. Bates, Amal Kaddoumi, John N.D. Wurpel, Yi-Xiong Lei & Zhe-Sheng Chen. (2018) Epidermal growth factor receptor (EGFR) inhibitor PD153035 reverses ABCG2-mediated multidrug resistance in non-small cell lung cancer: In vitro and in vivo. Cancer Letters 424, pages 19-29.
Crossref
Haidi Guan, Liucan Wang, Jixi Zhang, Yuxin Xing & Kaiyong Cai. (2018) Selective Enrichment of Polydopamine in Mesoporous Nanocarriers for Nuclear-Targeted Drug Delivery. Particle & Particle Systems Characterization 35:6, pages 1800011.
Crossref
Ying-Fang Fan, Wei Zhang, Leli Zeng, Zi-Ning Lei, Chao-Yun Cai, Pranav Gupta, Dong-Hua Yang, Qingbin Cui, Zuo-Dong Qin, Zhe-Sheng Chen & Louis D. Trombetta. (2018) Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters. Cancer Letters 421, pages 186-198.
Crossref
Risa Akizuki, Ryohei Maruhashi, Hiroaki Eguchi, Kazuki Kitabatake, Mitsutoshi Tsukimoto, Takumi Furuta, Toshiyuki Matsunaga, Satoshi Endo & Akira Ikari. (2018) Decrease in paracellular permeability and chemosensitivity to doxorubicin by claudin-1 in spheroid culture models of human lung adenocarcinoma A549 cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1865:5, pages 769-780.
Crossref
Katarzyna Mieszala, Malgorzata Rudewicz, Agnieszka Gomulkiewicz, Katarzyna Ratajczak‑Wielgomas, Jedrzej Grzegrzolka, Piotr Dziegiel & Sylwia Borska. (2018) Expression of genes and proteins of multidrug resistance in gastric cancer cells treated with resveratrol. Oncology Letters.
Crossref
Chenwei Wu, Li Xu, Leilei Shi, Xihui Gao, Jing Li, Xinyuan Zhu & Chuan Zhang. (2018) Supramolecularly self-assembled nano-twin drug for reversing multidrug resistance. Biomaterials Science 6:8, pages 2261-2269.
Crossref

Displaying 200 of 221 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.